Newsroom

Neuraxpharm expands Italian product portfolio with a well-established brand from Almirall
26 JUNE
Neuraxpharm Italy acquires Ansiolin^®, an anxiolytic prescription drug
Read more
Neuraxpharm launches the social initiative “Quarantine Together” to provide psychological support to families in Spain and Italy during COVID-19
02 APR
Families will receive free help and guidance in their homes from professional psychologists via telephone or email during times of social distancing
Read more
Neuraxpharm enters the advanced medical cannabis market in Germany with a collaboration with Panaxia
01 APR
Neuraxpharm enters the medical cannabis market as the first-ever European pharmaceutical company to market medical cannabis products
Read more
Corporate announcement: COVID-19 update
23 MAR
Corporate announcement: Update concerning novel coronavirus (COVID-19)
Read more
Neuraxpharm reinforces presence in Poland with the acquisition of Glenmark’s CNS product portfolio
25 FEB
Neuraxpharm acquires Glenmark’s CNS product portfolio in Poland along with its CNS commercial team and Jacek Sawicki is appointed General Manager of Neuraxpharm Polska as of 1^st April.
Read more

123 4 5 7

Neuraxpharm expands Italian product portfolio with a well-established brand from Almirall